Home » Topics » BioWorld Science

BioWorld Science
RSS

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Aug. 27, 2019

Basilea completes enrollment in phase I study of oral BAL-101553 in brain cancer

Aug. 27, 2019

DNA's sweet tooth linked to increased cancer risk with diabetes

Aug. 27, 2019

Ivy, Salarius Pharmaceuticals enter collaboration to develop new cancer treatment for glioblastoma

Aug. 27, 2019

Ubiquitin carboxyl-terminal hydrolase 19 inhibitors discovered at Almac Discovery

Aug. 27, 2019

Janssen presents respiratory syncytial virus replication inhibitors

Aug. 27, 2019

Heparegenix synthesizes new MAPKK 4 inhibitors

Aug. 27, 2019

New lysosomal acid glucosylceramidase inhibitors identified at Takeda

Aug. 27, 2019

Esteve Pharmaceuticals describes dual CACNA2D1/mu opioid receptor ligands

Aug. 27, 2019

IL-2-R336A fusion toxin enhances antitumor immune response in preclinical models

Aug. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...